These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Significant association between CYP1A1 T3801C polymorphism and cervical neoplasia risk: a systematic review and meta-analysis. Xia L, Gao J, Liu Y, Wu K. Tumour Biol; 2013 Feb; 34(1):223-30. PubMed ID: 23055196 [Abstract] [Full Text] [Related]
23. MDM2 309T>G polymorphism and risk of squamous cell carcinomas of head and neck: a meta-analysis. Liu J, Zheng Y, Lei D, Liu D, Xu F, Jin T, Cao X, Zhao X, Yu X, Pan X. Asian Pac J Cancer Prev; 2011 Feb; 12(8):1899-903. PubMed ID: 22292622 [Abstract] [Full Text] [Related]
25. Quantitative assessment of the association between XRCC3 C18607T polymorphism and glioma risk. Wang R, Li M, Gao WW, Gu Y, Guo Y, Wang G, Tian HL. Tumour Biol; 2014 Feb; 35(2):1101-5. PubMed ID: 24186073 [Abstract] [Full Text] [Related]
26. The association of IL1α and IL1β polymorphisms with susceptibility to systemic lupus erythematosus: a meta-analysis. Wang B, Zhu JM, Fan YG, Feng CC, Chen GM, Chen H, Pan HF, Ye DQ. Gene; 2013 Sep 15; 527(1):95-101. PubMed ID: 23747396 [Abstract] [Full Text] [Related]
27. CTLA-4 rs5742909 polymorphism and cervical cancer risk: A meta-analysis. Hu S, Pu D, Xia X, Guo B, Zhang C. Medicine (Baltimore); 2020 Mar 15; 99(11):e19433. PubMed ID: 32176070 [Abstract] [Full Text] [Related]
28. Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis. Zhou L, Yao F, Luan H, Wang Y, Dong X, Zhou W, Wang Q. Breast Cancer Res Treat; 2012 Dec 15; 136(3):885-97. PubMed ID: 23124475 [Abstract] [Full Text] [Related]
29. Association between transforming growth factor-beta 1 T869C polymorphism and ischemic stroke: a meta-analysis. Peng L, Li P, Chen J, Yan K, Huo F, Han L, Li C, Tan S, Jiang X. PLoS One; 2013 Dec 15; 8(7):e67738. PubMed ID: 23861796 [Abstract] [Full Text] [Related]
30. The interleukin 10 -819C/T polymorphism and cancer risk: a HuGE review and meta-analysis of 73 studies including 15,942 cases and 22,336 controls. Yu Z, Liu Q, Huang C, Wu M, Li G. OMICS; 2013 Apr 15; 17(4):200-14. PubMed ID: 23574339 [Abstract] [Full Text] [Related]
31. Association of the MTHFR C677T polymorphism with primary brain tumor risk. Xu C, Yuan L, Tian H, Cao H, Chen S. Tumour Biol; 2013 Dec 15; 34(6):3457-64. PubMed ID: 23846816 [Abstract] [Full Text] [Related]
33. NAD(P)H quinone oxidoreductase 1 (NQO1) genetic C609T polymorphism is associated with the risk of digestive tract cancer: a meta-analysis based on 21 case-control studies. Yang FY, Guan QK, Cui YH, Zhao ZQ, Rao W, Xi Z. Eur J Cancer Prev; 2012 Sep 15; 21(5):432-41. PubMed ID: 22387672 [Abstract] [Full Text] [Related]
34. The MDM2 SNP309T>G polymorphism increases bladder cancer risk among Caucasians: a meta-analysis. Wang HG, Wu QY, Zhou H, Peng XS, Shi MJ, Li JM, Zhou YF. Asian Pac J Cancer Prev; 2014 Sep 15; 15(13):5277-81. PubMed ID: 25040988 [Abstract] [Full Text] [Related]
37. The -137G>C polymorphism in interleukin-18 promoter region and cancer risk: evidence from a meta-analysis of 21 studies. Liang TJ, Ma H, Wang CX, Liu YR, Wang XG. Tumour Biol; 2013 Dec 15; 34(6):3483-90. PubMed ID: 23794112 [Abstract] [Full Text] [Related]
38. DNMT3B polymorphisms and cancer risk: a meta analysis of 24 case-control studies. Zhu S, Zhang H, Tang Y, Liu P, Wang J. Mol Biol Rep; 2012 Apr 15; 39(4):4429-37. PubMed ID: 21938431 [Abstract] [Full Text] [Related]
40. Significant associations between X-ray repair cross-complementing group 3 genetic polymorphisms and thyroid cancer risk. Yu XL, Liu H, Wang B, Fu ZJ, Yuan Y, Yan SL, Zhao WJ, Wang YG, Cai J. Tumour Biol; 2014 Mar 15; 35(3):2009-15. PubMed ID: 24277376 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]